Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
Go back to Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia| (NASDAQ: LRMR) | Delayed: 4.01 -0.01 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.02 | 52 Week High | $ | |||
| Open | $4.01 | 52 Week Low | $ | |||
| Day High | $4.10 | P/E | N/A | |||
| Day Low | $3.93 | EPS | $ | |||
| Volume | 698,700 | |||||
